Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avis Budget

61.95
+6.4611.64%
Post-market: 62.780.8320+1.34%19:43 EDT
Volume:2.11M
Turnover:126.99M
Market Cap:2.18B
PE:-1.21
High:63.18
Open:57.52
Low:55.69
Close:55.49
Loading ...

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

Business Wire
·
Yesterday

Why Black Cat, CAR Group, Data#3, and Helia shares are falling today

MotleyFool
·
Yesterday

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

GlobeNewswire
·
Yesterday

Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

GlobeNewswire
·
Yesterday

Avis Could Benefit If Tariffs Raise Car Prices -- Market Talk

Dow Jones
·
Yesterday

Why Is Avis Budget (CAR) Down 25.1% Since Last Earnings Report?

Zacks
·
13 Mar

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses

ACCESS Newswire
·
13 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney

Reuters
·
12 Mar

BUZZ-US travel-related shares tumble as airline forecasts fuel concerns

Reuters
·
12 Mar

CAR's Stock Drop Lures Returning Bull -- Market Talk

Dow Jones
·
11 Mar

2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

Business Wire
·
11 Mar

Press Release: Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
11 Mar

Avis Budget put volume heavy and directionally bearish

TIPRANKS
·
11 Mar

Q3 2025 America's CAR-MART Inc Earnings Call

Thomson Reuters StreetEvents
·
07 Mar

CAR Group (WN6) Gets a Buy from Citi

TIPRANKS
·
07 Mar

Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress

Business Wire
·
07 Mar